An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results

• Autors principals: Milan Barras (Autor), Lutz Schmitz (Autor), Chris Braumann (Autor), Waldemar Uhl (Autor), Marina Skrygan (Autor), Marie Buchholz (Autor), Thomas Meyer (Autor), Eggert Stockfleth (Autor), Thomas Müller (Autor), Jürgen C. Becker (Autor), Thilo Gambichler (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2023-03-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Advanced cutaneous squamous cell carcinoma (cSCC) can be a life-threatening disease for which effective and safe treatment in advanced stages is very limited. GP-2250 has been recently proven to have-in vitro and in vivo-antineoplastic effects on cancer cells. This study aims to investigate the pote...